Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 12 May 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 12 May 2026Mint
Health insurance share rises to 41% of non-life industry in FY26
Health insurance strengthened its position as the largest segment in India’s non-life insurance industry in FY26, with its share rising to 40.8% from 38.6% a year earlier. The segment grew 15.4% to about Rs 1.4 lakh crore, outpacing the overall non-life industry growth of 9.3%, which took total gross direct premium income close to Rs 3.4 lakh crore.
Biosimilar ramp-up to drive growth for Biocon in FY27
Recently launched biosimilars across markets have begun scaling up and will gather momentum through the year, particularly in the second half of FY27, the company's top executive said
Biocon reports 63% YoY fall in Q4 profit, final dividend of Rs. 0.50 recommended
Biocon's fourth-quarter net profit saw a significant drop of 63 percent year-on-year. This decline was attributed to exceptional charges impacting the company's financials. However, core businesses demonstrated growth. The company successfully integrated its biosimilars and generics operations. This strategic move aims to enhance scale and market reach. Biocon is now focused on improving profitability and creating long-term value for shareholders.
Vikram Solar shares slide 5% as Q4 margins take a hit; profit jumps 21% YoY
Vikram Solar shares fell sharply on Friday as Q4 margins contracted sharply, even though profit rose 21% year-on-year. Revenue grew 22% and EBITDA improved modestly, but a 300-bps margin decline weighed on sentiment. Despite strong FY26 growth, near-term cost pressures from China’s policy changes could affect pricing.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 8 May 2026
Chandan Taparia has recommended three stocks to buy today, 8 May 2026 - Bharat Dynamics, CG Power and Industrial Solutions and RBL Bank shares.
Hexaware Tech reiterates revenue, margin guidance for 2026; Stock declines after Q1
Hexaware Tech's healthcare and insurance vertical was the clear standout as it contributed to 22.6% of its revenue. The segment saw growth of 9.8% sequentially and 13.5% from the previous year.
Ruchit Jain of Motilal Oswal suggests Granules India, Nippon Life, and SRF shares to buy for the short term
The Nifty 50 and Sensex increased on May 6, supported by a government credit guarantee scheme for businesses. Investor sentiment improved due to positive earnings reports and falling oil prices, suggesting resilience in markets despite recent challenges.
Wockhardt shares surge over 12% to 9-month high as company swings to profit in Q4
Wockhardt's shares surged 12.55% to ₹1,604 following a profitable Q4FY26 with a net profit of ₹164 crore. Strong revenue growth from biotech and emerging markets fueled performance, with full-year revenue rising to ₹3,373 crore and EBITDA increasing by 51%.
Nippon India Mutual Fund raises stake in this healthcare stock. Do you own? - Mint
Nippon India Mutual Fund raises stake in this healthcare stock. Do you own?Mint
Wockhardt shares jump 10% after profitability returns in Q4, margins expand on revenue growth
Segment-wise, the India branded business posted steady growth, with Q4 revenue rising 18% to ₹112 crore from ₹95 crore last year. For the full year FY26, the segment grew 15% to ₹523 crore versus ₹456 crore.
Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growth
Wockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performance. Net profit turned positive, and revenue saw a substantial increase. Full-year earnings also showed improvement. Biotech operations were a key growth driver, with expansion in emerging markets. The company also expanded its product pipeline with new filings and approvals.